Thomas Catinazzo

Board Member

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

RLAY

Current role

Board Member, CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Relay Therapeutics, Inc. (RLAY)	Chief Financial Officer	$486,100	—	—	$874,500	$194,440	$13,573	$1,568,613
2024	Relay Therapeutics, Inc. (RLAY)	Chief Financial Officer	$481,276	—	$3,713,903	—	$192,510	$13,305	$4,400,994
2023	Relay Therapeutics, Inc. (RLAY)	Chief Financial Officer	$465,000	—	$1,855,945	$2,699,210	$186,000	$12,994	$5,219,149
2022	Relay Therapeutics, Inc. (RLAY)	Chief Financial Officer	$420,000	—	$800,323	$1,057,117	$168,000	$11,825	$2,457,265
2021	Relay Therapeutics, Inc. (RLAY)	Chief Financial Officer	$381,100	—	$543,548	$734,038	$166,731	$10,862	$1,836,279

No earnings-call appearances or filed executive changes recorded yet.